Stereotactic radiotherapy for lung and liver tumors using a body cast system

Setup accuracy and preliminary clinical outcome

Yoshiyuki Shioyama, Katsumasa Nakamura, Shigeo Anai, Tomonari Sasaki, Saiji Ooga, Madoka Saku, Yusuke Urashima, Tadamasa Yoshitake, Takashi Toba, Hiromi Terashima, Hiroshi Honda

研究成果: ジャーナルへの寄稿記事

24 引用 (Scopus)

抄録

Purpose: To evaluate the feasibility and treatment outcomes of stereotactic radiotherapy (SRT) using a newly developed simple body cast system for lung and liver tumors. Materials and Methods: From April 2003 to July 2004, 20 patients were treated with SRT at the Kyushu University Hospital. Thirteen patients had primary lung cancer, 5 had metastatic lung cancer, and 2 had hepatocellular carcinoma. All patients were fixed with a thermoplastic body cast combined with a vacuum pillow, arm and leg support, and a carbon plate. SRT was given in 5-8 fields with an isocenter dose of 48-60 Gy in 4-10 fractions. Target verification was performed by computed tomography (CT) during the first session, and by anterior-posterior (A-P) and lateral portal images during the second and subsequent sessions. Results: The average setup errors and deviation in the first treatment session were 1.4 ± 1.2, 1.1 ± 1.0, and 3.3 ± 2.8 mm in the lateral, A-P, and cranio-caudal (C-C) directions, respectively. The setup errors in the second and subsequent sessions were 2.4 ± 0.5, 1.4 ± 1.8, and 3.7 ± 2.6 mm in the lateral, A-P, and C-C directions, respectively. The patient's movement during a treatment session was within 5 mm in any direction. Despite the short follow-up periods (1-15 months), complete response was shown in 4 lesions, and partial response was shown in 15 lesions. Neither local progression nor serious complication was observed in any patient. Conclusion: SRT using our body cast system was a safe and reliable treatment method for extracranial tumors.

元の言語英語
ページ(範囲)407-413
ページ数7
ジャーナルRadiation Medicine - Medical Imaging and Radiation Oncology
23
発行部数6
出版物ステータス出版済み - 9 1 2005

Fingerprint

liver
lungs
casts
radiation therapy
Radiotherapy
tumors
Lung
Liver
cancer
Neoplasms
lesions
Lung Neoplasms
Vacuum
progressions
Hepatocellular Carcinoma
Leg
Arm
Therapeutics
Carbon
tomography

All Science Journal Classification (ASJC) codes

  • Radiation
  • Radiology Nuclear Medicine and imaging
  • Oncology

これを引用

Stereotactic radiotherapy for lung and liver tumors using a body cast system : Setup accuracy and preliminary clinical outcome. / Shioyama, Yoshiyuki; Nakamura, Katsumasa; Anai, Shigeo; Sasaki, Tomonari; Ooga, Saiji; Saku, Madoka; Urashima, Yusuke; Yoshitake, Tadamasa; Toba, Takashi; Terashima, Hiromi; Honda, Hiroshi.

:: Radiation Medicine - Medical Imaging and Radiation Oncology, 巻 23, 番号 6, 01.09.2005, p. 407-413.

研究成果: ジャーナルへの寄稿記事

Shioyama, Yoshiyuki ; Nakamura, Katsumasa ; Anai, Shigeo ; Sasaki, Tomonari ; Ooga, Saiji ; Saku, Madoka ; Urashima, Yusuke ; Yoshitake, Tadamasa ; Toba, Takashi ; Terashima, Hiromi ; Honda, Hiroshi. / Stereotactic radiotherapy for lung and liver tumors using a body cast system : Setup accuracy and preliminary clinical outcome. :: Radiation Medicine - Medical Imaging and Radiation Oncology. 2005 ; 巻 23, 番号 6. pp. 407-413.
@article{2603b797ed414c3a9b8c3984754418f2,
title = "Stereotactic radiotherapy for lung and liver tumors using a body cast system: Setup accuracy and preliminary clinical outcome",
abstract = "Purpose: To evaluate the feasibility and treatment outcomes of stereotactic radiotherapy (SRT) using a newly developed simple body cast system for lung and liver tumors. Materials and Methods: From April 2003 to July 2004, 20 patients were treated with SRT at the Kyushu University Hospital. Thirteen patients had primary lung cancer, 5 had metastatic lung cancer, and 2 had hepatocellular carcinoma. All patients were fixed with a thermoplastic body cast combined with a vacuum pillow, arm and leg support, and a carbon plate. SRT was given in 5-8 fields with an isocenter dose of 48-60 Gy in 4-10 fractions. Target verification was performed by computed tomography (CT) during the first session, and by anterior-posterior (A-P) and lateral portal images during the second and subsequent sessions. Results: The average setup errors and deviation in the first treatment session were 1.4 ± 1.2, 1.1 ± 1.0, and 3.3 ± 2.8 mm in the lateral, A-P, and cranio-caudal (C-C) directions, respectively. The setup errors in the second and subsequent sessions were 2.4 ± 0.5, 1.4 ± 1.8, and 3.7 ± 2.6 mm in the lateral, A-P, and C-C directions, respectively. The patient's movement during a treatment session was within 5 mm in any direction. Despite the short follow-up periods (1-15 months), complete response was shown in 4 lesions, and partial response was shown in 15 lesions. Neither local progression nor serious complication was observed in any patient. Conclusion: SRT using our body cast system was a safe and reliable treatment method for extracranial tumors.",
author = "Yoshiyuki Shioyama and Katsumasa Nakamura and Shigeo Anai and Tomonari Sasaki and Saiji Ooga and Madoka Saku and Yusuke Urashima and Tadamasa Yoshitake and Takashi Toba and Hiromi Terashima and Hiroshi Honda",
year = "2005",
month = "9",
day = "1",
language = "English",
volume = "23",
pages = "407--413",
journal = "Japanese Journal of Radiology",
issn = "1867-1071",
publisher = "Springer Japan",
number = "6",

}

TY - JOUR

T1 - Stereotactic radiotherapy for lung and liver tumors using a body cast system

T2 - Setup accuracy and preliminary clinical outcome

AU - Shioyama, Yoshiyuki

AU - Nakamura, Katsumasa

AU - Anai, Shigeo

AU - Sasaki, Tomonari

AU - Ooga, Saiji

AU - Saku, Madoka

AU - Urashima, Yusuke

AU - Yoshitake, Tadamasa

AU - Toba, Takashi

AU - Terashima, Hiromi

AU - Honda, Hiroshi

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Purpose: To evaluate the feasibility and treatment outcomes of stereotactic radiotherapy (SRT) using a newly developed simple body cast system for lung and liver tumors. Materials and Methods: From April 2003 to July 2004, 20 patients were treated with SRT at the Kyushu University Hospital. Thirteen patients had primary lung cancer, 5 had metastatic lung cancer, and 2 had hepatocellular carcinoma. All patients were fixed with a thermoplastic body cast combined with a vacuum pillow, arm and leg support, and a carbon plate. SRT was given in 5-8 fields with an isocenter dose of 48-60 Gy in 4-10 fractions. Target verification was performed by computed tomography (CT) during the first session, and by anterior-posterior (A-P) and lateral portal images during the second and subsequent sessions. Results: The average setup errors and deviation in the first treatment session were 1.4 ± 1.2, 1.1 ± 1.0, and 3.3 ± 2.8 mm in the lateral, A-P, and cranio-caudal (C-C) directions, respectively. The setup errors in the second and subsequent sessions were 2.4 ± 0.5, 1.4 ± 1.8, and 3.7 ± 2.6 mm in the lateral, A-P, and C-C directions, respectively. The patient's movement during a treatment session was within 5 mm in any direction. Despite the short follow-up periods (1-15 months), complete response was shown in 4 lesions, and partial response was shown in 15 lesions. Neither local progression nor serious complication was observed in any patient. Conclusion: SRT using our body cast system was a safe and reliable treatment method for extracranial tumors.

AB - Purpose: To evaluate the feasibility and treatment outcomes of stereotactic radiotherapy (SRT) using a newly developed simple body cast system for lung and liver tumors. Materials and Methods: From April 2003 to July 2004, 20 patients were treated with SRT at the Kyushu University Hospital. Thirteen patients had primary lung cancer, 5 had metastatic lung cancer, and 2 had hepatocellular carcinoma. All patients were fixed with a thermoplastic body cast combined with a vacuum pillow, arm and leg support, and a carbon plate. SRT was given in 5-8 fields with an isocenter dose of 48-60 Gy in 4-10 fractions. Target verification was performed by computed tomography (CT) during the first session, and by anterior-posterior (A-P) and lateral portal images during the second and subsequent sessions. Results: The average setup errors and deviation in the first treatment session were 1.4 ± 1.2, 1.1 ± 1.0, and 3.3 ± 2.8 mm in the lateral, A-P, and cranio-caudal (C-C) directions, respectively. The setup errors in the second and subsequent sessions were 2.4 ± 0.5, 1.4 ± 1.8, and 3.7 ± 2.6 mm in the lateral, A-P, and C-C directions, respectively. The patient's movement during a treatment session was within 5 mm in any direction. Despite the short follow-up periods (1-15 months), complete response was shown in 4 lesions, and partial response was shown in 15 lesions. Neither local progression nor serious complication was observed in any patient. Conclusion: SRT using our body cast system was a safe and reliable treatment method for extracranial tumors.

UR - http://www.scopus.com/inward/record.url?scp=26644455690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26644455690&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 407

EP - 413

JO - Japanese Journal of Radiology

JF - Japanese Journal of Radiology

SN - 1867-1071

IS - 6

ER -